← Back to Clinical Trials
Recruiting NCT05709470

NCT05709470 Mind the Heart - Mental Health in Children and Adolescents With Congenital Heart Defects

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05709470
Status Recruiting
Phase
Sponsor Rigshospitalet, Denmark
Condition Heart Defects, Congenital
Study Type OBSERVATIONAL
Enrollment 4,800 participants
Start Date 2023-03-17
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 5 Years
Max Age 17 Years
Study Type OBSERVATIONAL
Interventions
No-intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 4,800 participants in total. It began in 2023-03-17 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the Mind the Heart study is to document the feasibility of an online parent/child administered screening model for mental disorders (MDs) in Danish children and adolescents with congenital heart disease (CHD). As MDs in children and adolescents with chronic somatic health issues are frequently underdiagnosed and undertreated, we further aim to develop a website with evidence based information on mental health in children and adolescents with CHD in order to promote knowledge and awareness among families and health professionals across sectors.

Eligibility Criteria

Inclusion Criteria: * Born with a Congenital Heart Defect * Age 5-17y * (Living in Denmark) Exclusion Criteria: * Younger than 5years of age * Older than 17years of age * Lacking sufficient Danish language skills to answer the questionnaire

Contact & Investigator

Central Contact

Sara H Lau Jensen, M.D.

✉ sara.hirani.lau-jensen@regionh.dk

📞 004526192879

Principal Investigator

Vibeke E Hjortdal, M.D, PhD, professor

STUDY DIRECTOR

University of Copenhagen

Frequently Asked Questions

Who can join the NCT05709470 clinical trial?

This trial is open to participants of all sexes, aged 5 Years or older, up to 17 Years, studying Heart Defects, Congenital. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05709470 currently recruiting?

Yes, NCT05709470 is actively recruiting participants. Contact the research team at sara.hirani.lau-jensen@regionh.dk for enrollment information.

Where is the NCT05709470 trial being conducted?

This trial is being conducted at Copenhagen, Denmark.

Who is sponsoring the NCT05709470 clinical trial?

NCT05709470 is sponsored by Rigshospitalet, Denmark. The principal investigator is Vibeke E Hjortdal, M.D, PhD, professor at University of Copenhagen. The trial plans to enroll 4,800 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology